title: Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice.
abstract: Several cytokines, in particular tumor necrosis factor-alpha (TNF-alpha) and interferon-gamma (IFN-gamma), have been shown to be responsible for pathological reactions which may lead to shock and death observed in infection with Gram-negative bacteria and in response to endotoxins (lipopolysaccharides, LPS). Priming of mice with the avirulent Bacille Calmette Guérin (BCG) vaccine strain of Mycobacterium bovis increases the sensitivity of mice to the lethal effect of LPS and results in an efficient priming for cytokine production. In response to low doses (1 microgram/mouse) of LPS, BCG-primed mice produce interleukin-12 (IL-12) which controls IFN-gamma production, as demonstrated by the ability of neutralizing anti-IL-12 antibodies to suppress IFN-gamma production. However, the concentration of the biologically active IL-12 p70 heterodimer is similar in the serum of both BCG-primed or unprimed mice, reaching levels of 1-3 ng/ml at 3-6 h after LPS injection, whereas IFN-gamma production was observed only in BCG-primed mice. The priming effect of BCG on IFN-gamma production appears to be mostly due to its ability to increase TNF-alpha production, which acts as cofactor with LPS-induced IL-12 in inducing IFN-gamma production, as shown by the ability of injection of TNF-alpha and LPS (1 microgram/mouse), but not LPS alone, to induce IFN-gamma production. However, in addition to TNF-alpha, other LPS-induced cofactor(s) are required in cooperation with IL-12 to induce optimal IFN-gamma production, because co-injection of TNF-alpha and IL-12, sufficient to induce serum concentrations of both cytokines higher and more persistent than those obtained by injection of LPS, was not sufficient to induce IFN-gamma production in vivo. Neutralizing anti-IL-12 antibodies, in addition to inhibiting the in vivo LPS-induced IFN-gamma production, also completely protect BCG-primed mice injected with up to 10 micrograms of LPS from shock-induced death. Thus, IL-12 is required for IFN-gamma production and lethality in an endotoxic shock model in mice.
authors.affiliation: Wistar Institute of Anatomy and Biology, Philadelphia, PA 19104, USA.
authors.forename: M
authors.initials: M
authors.lastname: Wysocka
authors.forename: M
authors.initials: M
authors.lastname: Kubin
authors.forename: L Q
authors.initials: LQ
authors.lastname: Vieira
authors.forename: L
authors.initials: L
authors.lastname: Ozmen
authors.forename: G
authors.initials: G
authors.lastname: Garotta
authors.forename: P
authors.initials: P
authors.lastname: Scott
authors.forename: G
authors.initials: G
authors.lastname: Trinchieri
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D007371:Interferon-gamma / Q000096:biosynthesis*; D018664:Interleukin-12 / Q000096:biosynthesis* / Q000276:immunology*; D008070:Lipopolysaccharides; D051379:Mice; D008815:Mice, Inbred Strains; D016513:Mice, SCID; D012772:Shock, Septic / Q000276:immunology* / Q000401:mortality*
chemical_list: D000911:Antibodies, Monoclonal; D008070:Lipopolysaccharides; D018664:Interleukin-12; D007371:Interferon-gamma